Technostat   Report issue

For profit Phase 2
Founded: Ra'anana Israel (1993)
Status: No NME R&D (1993)

Organization Overview

First Clinical Trial
2012
NCT01509911
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2012

Timeline

NOW
  • Now

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Pancreatic Neoplasms (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 1
  • # of Trial APIs: 5